|
|
Department of Defense Inspector General
DDIG 6/25/2008 | 0 (0) | 108 | 4 | 0 | English
DDIG 6/25/2008 | 0 (0) | 52 | 0 | 0 | English
Joint Platform Interior Decontamination (JPID)
Description: The JPID system will decontaminate chemical and biological warfare agents on the interior of aircraft, vehicles, ships and interior buildings. Currently no such capability exists. JPID will be a family of systems under two increments. Increment I will provide capabilities to decontaminate ... more>>
DDIG 6/25/2008 | 0 (0) | 64 | 0 | 0 | English
Critical Reagents Program (CRP)
Description: CRP products such as antibodies, select agent antigens, nucleic acid panels, Electrochemiluminescence (ECL) Immunoassays, Polymerase Chain Reaction (PCR) assays, Hand Held Assays (HHAs), and Biological Sampling Kits are crucial to the mission of all current and future Department of Defense (DoD) Biologic ... more>>
DDIG 6/25/2008 | 0 (0) | 51 | 0 | 0 | English
Joint Biological Agent Identification and Diagnostic System (JBAIDS)
Description: The Joint Biological Agent Identification and Diagnostic System (JBAIDS) is an integrated system for rapid identification and diagnostic confirmation of biological agent exposure or infection. Based on commercial technology, JBAIDS is man-portable, reusable, and will ... more>>
DDIG 6/25/2008 | 0 (0) | 47 | 0 | 0 | English
DDIG 6/25/2008 | 0 (0) | 51 | 0 | 0 | English
Medical Aerosolized Nerve Agent Antidote (MANAA)
Description: MANAA (NSN 6505-01-332-1281) is an aerosol inhalant device used to administer the nerve agent antidote, atropine, for the treatment of nerve agent-induced effects. It is used mainly in medical treatment facilities by the individual casualty under medical supervision for symptomatic reli ... more>>
DDIG 6/25/2008 | 0 (0) | 52 | 0 | 0 | English
Bioscavenger Increment I Plasma-derived butyrylcholinesterase
Description: Nerve agents (e.g., soman, sarin, VX) are fast acting and lethal at low doses. Bioscavenger will be used as a prophylaxis to prevent incapacitation and death from exposure to nerve agents. Bioscavenger Increment I is human butyrylcholinesterase (HuBChE), a naturally occurrin ... more>>
DDIG 6/25/2008 | 0 (0) | 56 | 0 | 0 | English
Improved Nerve Agent Treatment System (INATS)
Description: The INATS is an enhanced treatment regimen designed to provide protection against a broad spectrum of nerve agents. The components of INATS include (1) replacing the currently fielded oxime (2-pralidoxime chloride, 2-PAM) with a new oxime and (2) obtaining approval for use of pyridostigmine ... more>>
DDIG 6/25/2008 | 0 (0) | 57 | 0 | 0 | English
Anthrax Vaccine Adsorbed (AVA)
Description: AVA is an FDA-licensed vaccine produced by BioPort Corporation under the trade name BioThrax TM. The vaccine is a sterile cellfree filtrate containing proteins, including the 83kDa protective antigen protein, made from an avirulent strain of Bacillus anthracis. It is given in a 6-shot regimen with an annu ... more>>
DDIG 6/25/2008 | 0 (0) | 67 | 0 | 0 | English
Convulsant Antidote for Nerve Agents (CANA)
Description: The Food and Drug Administration approved CANA (NSN 6505-01-274-0951) is an autoinjector containing 10 mg diazepam for intramuscular administration to control nerve agent-induced seizures. Administration of atropine and 2pralidoxime-chloride (2-PAM) alone often does not prevent the occurrence ... more>>
DDIG 6/25/2008 | 0 (0) | 54 | 0 | 0 | English
DDIG 6/25/2008 | 0 (0) | 40 | 0 | 0 | English
Advanced Anticonvulsant System (AAS)
Description: The AAS consists of the drug midazolam, in an autoinjector, for treatment of nerve agentinduced seizures and the prevention of subsequent neurological damage. Exposure to nerve agents may produce long-lasting convulsions even after treatment with atropine and 2-PAM. Untreated, these convulsions will ... more>>
DDIG 6/25/2008 | 0 (0) | 54 | 0 | 0 | English
Antidote Treatment – Nerve Agent, Autoinjector (ATNAA)
Description: The Food and Drug Administration-approved ATNAA (NSN 6505-01-362-7427) is a 2chambered autoinjector used for the intramuscular injection of the nerve agent antidotes atropine and 2-pralidoxime chloride (2-PAM) through the same needle. The ATNAA is administered after onset of sympto ... more>>
DDIG 6/25/2008 | 0 (0) | 44 | 0 | 0 | English
DDIG 6/25/2008 | 0 (0) | 45 | 0 | 0 | English
|